Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3.20x is in line with its 1-year average of -3.41x, around the middle of its 1-year range (-4.19x–-2.48x).
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -2.48x.
INTEREST COVERAGE RATIO
-3.20x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+50.31%
vs the sector median at left
Starling Oncology, Inc.
Market Cap
$657.89M
Interest Coverage Ratio
-3.20x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$656.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$666.95M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$673.41M
Interest Coverage Ratio
35.83x
TTM Avg
47.17x
3Y Avg
33.36x
5Y Avg
33.36x
Market Cap
$638.20M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$681.02M
Interest Coverage Ratio
-149.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$681.27M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$634.30M
Interest Coverage Ratio
-0.53x
TTM Avg
20.56x
3Y Avg
20.56x
5Y Avg
20.56x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | $657.89M | -3.20x | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $660.29M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $666.95M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 35.83x | 47.17x | 33.36x | 33.36x |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | N/A | N/A | N/A | N/A |
| Verastem, Inc. (VSTM)vs › | $681.02M | -149.50x | N/A | N/A | N/A |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | N/A | N/A | N/A | N/A |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | -0.53x | 20.56x | 20.56x | 20.56x |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | N/A | N/A | N/A | N/A |
Interest Coverage
-3.2x
Debt/Equity
N/A
Current Ratio
1.36
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -2.48x |
| 2026-03-31 | -3.37x |
| 2025-12-31 | -3.60x |
| 2025-09-30 | -4.19x |
